PITTSBURGH, Dec. 03 /CSRwire/ - Greg Babe, President and CEO of Bayer Corporation and Bayer MaterialScience LLC, will serve as executive chair of the American Chemistry Council's (ACC) Responsible Care$reg; Board Committee, Bayer announced today. Babe will succeed Oxy Chem CEO Chuck Anderson on January 1, 2010, and serve for three years.
"The chemical industry remains committed to the Responsible Care program and its mission of continuous improvement in the industry’s health, safety and environmental performance," said Babe. "Under Chuck Anderson's leadership, the program continued to make great strides, and we will look to build on this momentum in 2010."
Babe brings more than 30 years of chemical industry experience at Bayer to this new role. He has held several management positions of increasing responsibility including manager of chemical facilities in the U.S. and Germany. As executive chair, Babe will direct the strategic review of the Responsible Care program to ensure that it meets the future needs of the industry and its stakeholders.
"We are fortunate an industry leader of Greg’s standing is assuming the duties of Chairman for the Responsible Care Board Committee,” said Cal Dooley, ACC’s President and CEO. "He will follow a great leader in Chuck Anderson, and we are counting on Greg's vision and strategic leadership to help take Responsible Care to the next level, broadening linkages to sustainability, enhancing safe management of chemical products and promoting sound practices throughout the supply chain."
The ACC established its Responsible Care program in 1988 to focus on the areas of health, environment, safety and security. Participation is mandatory for all ACC member companies, who commit to meet defined performance and ethical standards. Since the Sept. 11, 2001, terrorist attacks, the chemistry industry has invested nearly $8 billion in security enhancements under the Responsible Care Security Code, the ACC reports.
Responsible Care is also a worldwide initiative. It is practiced by 53 national associations, which share a common global commitment to advancing the safe and secure management of chemical products and processes.
About Bayer Corporation
Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and high-tech materials group based in Leverkusen, Germany. In North America, Bayer had 2008 net sales of approximately 8 billion euros (about $12 billion) and employed 17,000 at year-end. Bayer's three subgroups, Bayer HealthCare, Bayer CropScience and Bayer MaterialScience, improve people's lives through a broad range of essential products that help diagnose, prevent and treat diseases; protect crops and enhance yields; and advance automobile safety and durability. For more information, go to .
About the American Chemistry Council
The American Chemistry Council (ACC) represents the leading companies engaged in the business of chemistry. ACC members apply the science of chemistry to make innovative products and services that make people's lives better, healthier and safer. ACC is committed to improved environmental, health and safety performance through Responsible Care®, common sense advocacy designed to address major public policy issues, and health and environmental research and product testing. The business of chemistry is a $689 billion enterprise and a key element of the nation's economy. It is one of the nation's largest exporters, accounting for ten cents out of every dollar in U.S. exports. Chemistry companies are among the largest investors in research and development. Safety and security have always been primary concerns of ACC members, and they have intensified their efforts, working closely with government agencies to improve security and to defend against any threat to the nation’s critical infrastructure.
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
For more information, please contact:
For more from this organization:Bayer